Pulmonary Artery Catheters May Improve Heart Failure Quality Of Life
This article was originally published in The Gray Sheet
Pulmonary artery catheterization (PAC) of severe heart failure patients is not associated with lower mortality, although it may assist doctors in improving patient quality of life, according to ESCAPE trial findings
You may also be interested in...
PULMONARY ARTERY CATHETER RESEARCH PROPOSALS TO BE REVIEWED BY NHLBI advisory board on Sept. 4. The National Heart, Lung and Blood Institute's advisory panel is slated to review research proposals developed at an Aug. 25-26 workshop in Alexandria, Virginia sponsored by FDA and the National Institutes of Health to address questions about the safety and effectiveness of pulmonary artery catheters.
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.